coin-img-ETHETH+1.80%coin-img-BTCBTC+1.30%coin-img-SOLSOL+2.05%coin-img-USDCUSDC-0.02%coin-img-UBOXUBOX-53.66%coin-img-XRPXRP+2.20%coin-img-HYPEHYPE-1.73%coin-img-TRXTRX+0.70%coin-img-ETHETH+1.80%coin-img-BTCBTC+1.30%coin-img-SOLSOL+2.05%coin-img-USDCUSDC-0.02%coin-img-UBOXUBOX-53.66%coin-img-XRPXRP+2.20%coin-img-HYPEHYPE-1.73%coin-img-TRXTRX+0.70%coin-img-ETHETH+1.80%coin-img-BTCBTC+1.30%coin-img-SOLSOL+2.05%coin-img-USDCUSDC-0.02%coin-img-UBOXUBOX-53.66%coin-img-XRPXRP+2.20%coin-img-HYPEHYPE-1.73%coin-img-TRXTRX+0.70%coin-img-ETHETH+1.80%coin-img-BTCBTC+1.30%coin-img-SOLSOL+2.05%coin-img-USDCUSDC-0.02%coin-img-UBOXUBOX-53.66%coin-img-XRPXRP+2.20%coin-img-HYPEHYPE-1.73%coin-img-TRXTRX+0.70%
user-avatar
CNBC TV18

Rainbow Children’s Medicare Q1 profit climbs 13.2% as revenue rises 33.2%

AI Market Summary
Rainbow Children's Medicare reported strong Q1 results, with revenue up 33.2% YoY and EBITDA up 29.9%, while net profit rose 13.2%. A slight EBITDA margin dip to 28.7% indicates modest cost pressure but overall operating momentum remains intact. The stock rose 2.16% post-results, signaling supportive sentiment toward Indian private healthcare growth, with limited broader cross-asset implications.
Impact level
● Low
Affected assets
NCCOGOLD2USD/USDT+2.18%
AI Insight · NCCOGOLD2USD/USDTAI Insight
● Neutral
Trade now
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
Rainbow Children’s Medicare reported fiscal 2024 first-quarter revenue of ₹469.99 crore, up 33.2% year on year. Net profit rose 13.2% to ₹60.57 crore, while EBITDA increased 29.9% to ₹134.65 crore. EBITDA margin edged down to 28.7%, though results were still markedly stronger than a year earlier. The company is one of India’s leading paediatric specialty hospital chains, and its performance reflects rising domestic healthcare spending and operational efficiency at private hospitals.
Disclaimer: The content above is only the author's opinion and does not represent BingX’s stance. It shall not be construed as investment advice from BingX. For details, refer to the Terms and Conditions.
Stocks

Risk Warning

Cryptocurrencies and their derivatives are innovative financial products with great volatility and high investment risks.

Although BingX is committed to providing users with easy-to-use trading tools, trading itself is still a highly sophisticated field. Trading digital assets and their derivatives are subject to high market risk and price volatility and may result in partial or total loss of account funds. You must carefully consider and exercise clear judgment to evaluate your financial situation and the aforementioned risks before using BingX Services. You shall be responsible for all losses arising therefrom. If necessary, please consult relevant professionals to make informed decisions before investing. By accessing, downloading, using or clicking on "I agree" to accept any BingX Services provided by BingX, you agree that you have read, understood and accepted all of the terms and conditions stipulated in BingX Terms of Use as well as our Privacy Policy.


Trading by copying or replicating the trades of other traders involves a high level of risks, even when copying or replicating the top-performing traders. Past performance of a BingX community member is not a reliable indicator of his future performance. Content on BingX's trading platform is generated by members of its community and does not contain advice or recommendations by or on behalf of BingX.